查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1956796

放射肿瘤市场分析及预测（至2035年）：依类型、产品类型、服务、技术、应用、最终用户、组件、设备、解决方案、安装类型划分

Radiation Oncology Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Equipment, Solutions, Installation Type
出版日期: | 出版商: Global Insight Services | 英文 367 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计放射肿瘤学市场规模将从2024年的83亿美元成长到2034年的172亿美元，复合年增长率约为7.1%。放射肿瘤学市场涵盖了利用直线加速器和质子治疗等先进技术开发和应用放射线治疗治疗癌症。该领域专注于精准标靶化肿瘤，同时最大限度地减少对周围组织的损伤。在癌症发病率上升和技术进步的推动下，影像和治疗计划的创新至关重要。对非侵入性癌症治疗日益增长的需求以及患者预后的改善，有望推动市场成长。

放射肿瘤市场预计将受益于技术进步和癌症发生率的上升而成长。体外放射治疗领域尤为突出，其中直线加速器因其精准高效而占据主导地位。质子治疗作为外照射放射治疗的一个子领域，因其能够标靶治疗而备受关注。近距离放射是表现第二好的领域，它提供了一种副作用极小的局部治疗选择。在近距离放射领域，高剂量率（HDR）近距离放射因其能够在短时间内输送精确的放射剂量而成为首选治疗方法。影像导航放射治疗（IGRT）和强度调控放射治疗（IMRT）也发展迅速，提高了治疗精度和患者疗效。治疗计划软体和治疗系统的创新进一步推动了市场成长。人工智慧和机器学习在治疗通讯协定中的应用正在优化患者护理，提供个人化治疗方案，并改善治疗效果。随着医疗机构不断采用先进技术，预计市场将持续扩张。

市场区隔
类型 体外放射治疗、体内放射治疗及全身放射线治疗
产品 直线加速器、质子治疗系统、近距离放射设备、软体解决方案
服务 治疗方案製定服务、咨询服务、维护服务、训练和教育服务
科技 影像导航放射治疗（IGRT）、强度调控放射治疗（IMRT）、立体定位技术、质子治疗、三维适形放射治疗
适用的 乳癌、摄护腺癌、肺癌、结肠癌、头颈癌、儿童癌症
最终用户 医院、癌症研究所、门诊放射治疗中心和专科诊所
成分 放射线照射设备、放射治疗模拟器、治疗计画系统、放射防护设备
装置 治疗设备、类比设备、品质保证设备
解决方案 肿瘤资讯系统、治疗计画系统、病患定位系统
安装类型 新安装、升级和改造

放射肿瘤市场呈现市场占有率分布多元化的特点，既有老牌企业，也有积极推出新产品的创新新参与企业。定价策略差异显着，受技术进步和区域经济状况的影响。尖端放射治疗系统和软体解决方案的引入，透过提高治疗精度和改善患者疗效，正在改变市场格局。这些创新推动着市场向前发展，供应商透过提供卓越的产品脱颖而出。竞争标竿研究揭示了主要产业参与者之间动态的互动关係。主要企业正透过策略联盟和技术创新争夺主导。监管影响至关重要，严格的标准和核准影响市场准入和扩张。北美和欧洲维持严格的监管，塑造竞争格​​局。同时，亚太地区的新兴市场，在医疗保健投资不断增长的推动下，蕴藏着盈利机会。这份全面的市场分析强调了法规结构和竞争策略在驾驭这个复杂且不断变化的领域中所扮演的关键角色。

主要趋势和驱动因素：

受癌症治疗方法技术进步的推动，放射肿瘤市场正经历强劲成长。关键趋势包括将人工智慧融入治疗计划和实施，从而提高治疗的精准度和患者疗效。质子治疗和立体定位放射放射线手术的兴起也值得关注，它们能够提供副作用极小的标靶治疗。此外，个人化医疗的普及正在改变肿瘤治疗，使基于基因分析的个人化治疗成为可能。全球癌症发生率的不断上升推动了市场成长，也促使人们寻求更先进的治疗方案。对非侵入性治疗的需求日益增长，推动了放射线治疗的广泛应用。政府对医疗基础设施和研究的投入进一步促进了市场扩张。此外，人们对癌症早期检测和治疗的意识提升，也推动了对放射肿瘤服务的需求。新兴市场蕴藏着许多机会，这些市场的医疗体係正在发展，获得先进治疗的机会也不断改善。能够提供创新、经济高效、前沿解决方案的公司将占据有利地位，从而获得可观的市场份额。提高病患生活品质和缩短治疗时间的理念持续推动着创新放射技术的应用。随着研发的进步，放射肿瘤学市场预计将持续成长。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 体外放射治疗
    • 体内放射疗法
    • 全身放射线治疗
  • 市场规模及预测：依产品划分
    • 直线加速器
    • 质子治疗系统
    • 近距离放射机
    • 软体解决方案
  • 市场规模及预测：依服务划分
    • 治疗计划服务
    • 咨询服务
    • 维护服务
    • 培训和教育
  • 市场规模及预测：依技术划分
    • 影像导航放射治疗（IGRT）
    • 强度调控放射治疗（IMRT）
    • 立体定位放射治疗技术
    • 质子治疗
    • 3D适形放射治疗
  • 市场规模及预测：依应用领域划分
    • 乳癌
    • 摄护腺癌
    • 肺癌
    • 大肠直肠癌
    • 头颈癌
    • 儿童癌症
  • 市场规模及预测：依最终用户划分
    • 医院
    • 癌症研究所
    • 门诊放射治疗中心
    • 专科诊所
  • 市场规模及预测：依组件划分
    • 辐射照射设备
    • 放射治疗模拟器
    • 治疗计划系统
    • 辐射防护设备
  • 市场规模及预测：依设备划分
    • 治疗设备
    • 类比设备
    • 品质保证设备
  • 市场规模及预测：按解决方案划分
    • 肿瘤资讯系统
    • 治疗计划系统
    • 病人定位系统
  • 市场规模及预测：依安装类型划分
    • 新推出
    • 升级
    • 改装

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Varian Medical Systems
  • Elekta
  • Accuray
  • View Ray
  • IBA Proton Therapy
  • Mevion Medical Systems
  • Pro Tom International
  • Ray Search Laboratories
  • Brainlab
  • C-RAD
  • ZAP Surgical Systems
  • Refle Xion Medical
  • Theragenics Corporation
  • Nordion
  • Bionix Radiation Therapy
  • Qfix
  • Orfit Industries
  • CIVCO Radiotherapy
  • Modus Medical Devices
  • Scandi Dos

第九章：关于我们

简介目录
Product Code: GIS21407

Radiation Oncology Market is anticipated to expand from $8.3 billion in 2024 to $17.2 billion by 2034, growing at a CAGR of approximately 7.1%. The Radiation Oncology Market encompasses the development and application of radiation therapy for cancer treatment, leveraging advanced technologies like linear accelerators and proton therapy. This sector focuses on precision targeting of tumors, minimizing damage to surrounding tissues. Innovations in imaging and treatment planning are pivotal, driven by rising cancer incidence and technological advancements. The market is poised for growth, fueled by increasing demand for non-invasive cancer treatments and improvements in patient outcomes.

The Radiation Oncology Market is poised for growth, driven by technological advancements and increasing cancer prevalence. The external beam radiation therapy segment stands out, with linear accelerators leading due to their precision and efficacy. Proton therapy, a sub-segment, is gaining traction for its targeted treatment capabilities. Brachytherapy follows as the second highest-performing segment, offering localized treatment options with minimal side effects. Within brachytherapy, high-dose rate (HDR) brachytherapy is emerging as a preferred choice for its ability to deliver precise radiation doses in shorter time frames. Image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT) are also gaining momentum, enhancing treatment accuracy and patient outcomes. Innovations in treatment planning software and delivery systems are further propelling market growth. The integration of AI and machine learning in treatment protocols is optimizing patient care, offering personalized treatment plans and improving therapeutic efficacy. The market is set to expand as healthcare providers continue to adopt advanced technologies.

Market Segmentation
TypeExternal Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiation Therapy
ProductLinear Accelerators, Proton Therapy Systems, Brachytherapy Equipment, Software Solutions
ServicesTreatment Planning Services, Consultation Services, Maintenance Services, Training and Education
TechnologyImage-guided Radiotherapy (IGRT), Intensity-modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, 3D Conformal Radiotherapy
ApplicationBreast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Head and Neck Cancer, Pediatric Cancer
End UserHospitals, Cancer Research Institutes, Ambulatory Radiotherapy Centers, Specialty Clinics
ComponentRadiation Delivery Devices, Radiotherapy Simulators, Treatment Planning Systems, Radiation Safety Equipment
EquipmentTreatment Machines, Simulation Machines, Quality Assurance Instruments
SolutionsOncology Information Systems, Treatment Planning Systems, Patient Positioning Systems
Installation TypeNew Installation, Upgrades, Retrofits

The Radiation Oncology Market is characterized by a diverse array of market share distribution, with established players and innovative entrants actively launching new products. Pricing strategies vary significantly, influenced by technological advancements and regional economic conditions. The introduction of cutting-edge radiation therapy systems and software solutions is reshaping the landscape, offering enhanced precision and patient outcomes. These innovations are propelling the market forward, as providers seek to differentiate themselves through superior offerings. Competitive benchmarking reveals a dynamic interplay among key industry participants, with leading companies vying for dominance through strategic alliances and technological innovation. Regulatory influences are pivotal, as stringent standards and approvals impact market entry and expansion. North America and Europe maintain regulatory rigor, shaping the competitive environment. Meanwhile, emerging markets in Asia-Pacific present lucrative opportunities, driven by increasing healthcare investments. A comprehensive market analysis highlights the critical role of regulatory frameworks and competitive strategies in navigating this complex and evolving sector.

Geographical Overview:

The radiation oncology market is witnessing notable growth across various regions, each presenting unique opportunities. North America remains at the forefront, driven by advanced healthcare infrastructure and significant investment in oncology research. The region's focus on early cancer detection and treatment innovation further propels market expansion. Europe follows closely, with robust healthcare systems and a strong emphasis on cancer care. The region's commitment to technological advancements in radiation therapy enhances its market position. Meanwhile, the Asia Pacific region is emerging as a lucrative growth pocket, spurred by increasing cancer incidence and healthcare expenditure. Countries like China and India are at the forefront, with substantial investments in healthcare infrastructure and technology. Latin America and the Middle East & Africa are also gaining traction as emerging markets. These regions are recognizing the importance of modern radiation oncology techniques in improving cancer treatment outcomes and are investing accordingly to drive future growth.

The Radiation Oncology Market is navigating complex geopolitical landscapes and evolving supply chain dynamics. Global tariffs, particularly on medical equipment and technology, are influencing market strategies in Japan, South Korea, China, and Taiwan. Japan and South Korea are bolstering their domestic production capabilities to mitigate tariff-induced cost pressures. China, facing export controls, is accelerating its development of indigenous radiation oncology technologies. Taiwan's semiconductor prowess positions it as a vital supplier, yet it remains vulnerable to geopolitical tensions. The global market is expanding, driven by technological advancements and rising cancer prevalence, with expectations to evolve significantly by 2035. Middle East conflicts contribute to volatile energy prices, affecting production costs and supply chain stability, underscoring the need for strategic diversification and regional cooperation.

Key Trends and Drivers:

The Radiation Oncology Market is experiencing robust growth, propelled by technological advancements in cancer treatment modalities. Key trends include the integration of artificial intelligence in treatment planning and delivery, enhancing precision and patient outcomes. The rise of proton therapy and stereotactic radiosurgery is also notable, offering targeted treatment with minimal side effects. Furthermore, the adoption of personalized medicine is transforming oncology care, allowing for tailored therapies based on genetic profiling. Drivers of this market include the increasing global incidence of cancer, necessitating advanced treatment options. There is a growing demand for non-invasive procedures, contributing to the popularity of radiation therapy. Government investments in healthcare infrastructure and research are further accelerating market expansion. Additionally, the rising awareness and emphasis on early cancer detection and treatment are boosting the demand for radiation oncology services. Opportunities abound in emerging markets where healthcare systems are evolving, and access to advanced treatments is improving. Companies that innovate and offer cost-effective, cutting-edge solutions are well-positioned to capture significant market share. The focus on improving patient quality of life and reducing treatment times continues to drive innovation and adoption of novel radiation technologies. With ongoing research and development, the Radiation Oncology Market is poised for sustained growth.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Equipment
  • 2.9 Key Market Highlights by Solutions
  • 2.10 Key Market Highlights by Installation Type

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 External Beam Radiation Therapy
    • 4.1.2 Internal Radiation Therapy
    • 4.1.3 Systemic Radiation Therapy
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Linear Accelerators
    • 4.2.2 Proton Therapy Systems
    • 4.2.3 Brachytherapy Equipment
    • 4.2.4 Software Solutions
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Treatment Planning Services
    • 4.3.2 Consultation Services
    • 4.3.3 Maintenance Services
    • 4.3.4 Training and Education
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Image-guided Radiotherapy (IGRT)
    • 4.4.2 Intensity-modulated Radiotherapy (IMRT)
    • 4.4.3 Stereotactic Technology
    • 4.4.4 Proton Beam Therapy
    • 4.4.5 3D Conformal Radiotherapy
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Breast Cancer
    • 4.5.2 Prostate Cancer
    • 4.5.3 Lung Cancer
    • 4.5.4 Colorectal Cancer
    • 4.5.5 Head and Neck Cancer
    • 4.5.6 Pediatric Cancer
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Cancer Research Institutes
    • 4.6.3 Ambulatory Radiotherapy Centers
    • 4.6.4 Specialty Clinics
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Radiation Delivery Devices
    • 4.7.2 Radiotherapy Simulators
    • 4.7.3 Treatment Planning Systems
    • 4.7.4 Radiation Safety Equipment
  • 4.8 Market Size & Forecast by Equipment (2020-2035)
    • 4.8.1 Treatment Machines
    • 4.8.2 Simulation Machines
    • 4.8.3 Quality Assurance Instruments
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Oncology Information Systems
    • 4.9.2 Treatment Planning Systems
    • 4.9.3 Patient Positioning Systems
  • 4.10 Market Size & Forecast by Installation Type (2020-2035)
    • 4.10.1 New Installation
    • 4.10.2 Upgrades
    • 4.10.3 Retrofits

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Equipment
      • 5.2.1.9 Solutions
      • 5.2.1.10 Installation Type
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Equipment
      • 5.2.2.9 Solutions
      • 5.2.2.10 Installation Type
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Equipment
      • 5.2.3.9 Solutions
      • 5.2.3.10 Installation Type
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Equipment
      • 5.3.1.9 Solutions
      • 5.3.1.10 Installation Type
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Equipment
      • 5.3.2.9 Solutions
      • 5.3.2.10 Installation Type
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Equipment
      • 5.3.3.9 Solutions
      • 5.3.3.10 Installation Type
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Equipment
      • 5.4.1.9 Solutions
      • 5.4.1.10 Installation Type
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Equipment
      • 5.4.2.9 Solutions
      • 5.4.2.10 Installation Type
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Equipment
      • 5.4.3.9 Solutions
      • 5.4.3.10 Installation Type
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Equipment
      • 5.4.4.9 Solutions
      • 5.4.4.10 Installation Type
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Equipment
      • 5.4.5.9 Solutions
      • 5.4.5.10 Installation Type
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Equipment
      • 5.4.6.9 Solutions
      • 5.4.6.10 Installation Type
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Equipment
      • 5.4.7.9 Solutions
      • 5.4.7.10 Installation Type
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Equipment
      • 5.5.1.9 Solutions
      • 5.5.1.10 Installation Type
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Equipment
      • 5.5.2.9 Solutions
      • 5.5.2.10 Installation Type
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Equipment
      • 5.5.3.9 Solutions
      • 5.5.3.10 Installation Type
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Equipment
      • 5.5.4.9 Solutions
      • 5.5.4.10 Installation Type
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Equipment
      • 5.5.5.9 Solutions
      • 5.5.5.10 Installation Type
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Equipment
      • 5.5.6.9 Solutions
      • 5.5.6.10 Installation Type
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Equipment
      • 5.6.1.9 Solutions
      • 5.6.1.10 Installation Type
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Equipment
      • 5.6.2.9 Solutions
      • 5.6.2.10 Installation Type
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Equipment
      • 5.6.3.9 Solutions
      • 5.6.3.10 Installation Type
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Equipment
      • 5.6.4.9 Solutions
      • 5.6.4.10 Installation Type
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Equipment
      • 5.6.5.9 Solutions
      • 5.6.5.10 Installation Type

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Varian Medical Systems
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Elekta
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Accuray
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 View Ray
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 IBA Proton Therapy
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Mevion Medical Systems
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Pro Tom International
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Ray Search Laboratories
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Brainlab
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 C- RAD
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 ZAP Surgical Systems
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Refle Xion Medical
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Theragenics Corporation
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Nordion
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Bionix Radiation Therapy
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Qfix
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Orfit Industries
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 CIVCO Radiotherapy
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Modus Medical Devices
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Scandi Dos
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us